Bullish vs. Bearish (3 opinions)
Social Sentiment -0.05
ADMS Forecast and Technical Stock Analysis
Hold candidate since 2019-09-19 Gain 8.59% PDF
Adamas Pharmaceuticals gained 8.59% in the last trading day ( Friday, 20th Sep 2019 ), rising from $6.75 to $7.33 , and has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 9.94% from a day low at $6.74 to a day high of $7.41. The price has risen in 8 of the last 10 days and is up by 25.3% over the past 2 weeks. Volume fell in the last day by -0.04 million shares and in total, 1.42 million shares bought and sold for approximately $10.42 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
- 30 day high of the ADMS stock price was $7.41 and low was $5.43.
- 90 day high was $7.41 and low was $4.87.
- 52 week high for Adamas Pharmaceuticals - $20.63 and low - $4.20.
Adamas Pharmaceuticals has broken the wide and weak rising the short-term trend up and an even stronger rising rate is indicated. For any reaction back there will now be support on the roof on the current trend broken at $6.60, a level that may pose a second chance to hit a runner. According to fan-theory $7.55 will be the next possible trend-top level and thereby pose a resistance level which may not be broken at the first attempt.
Adamas Pharmaceuticals holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $6.55 and $6.17. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday September 09, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 69 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $6.31 and $6.05.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Adamas Pharmaceuticals finds support just below today's level at $6.31. If this is broken, then the next support from accumulated volume will be at $6.05 and $6.00.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.67 between high and low, or 9.94%. For the last week, the stock has had a daily average volatility of 7.49%.
Our recommended stop-loss: $7.06 (-3.66%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 9 days ago.)
7.49 %Average volatility
Very Low Low Medium High Very High
|ADMS $7.33 ($0.58 8.59%)|
ADMS is up $0.58 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ADMS based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ADMS analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!